Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Pilot Implementation of Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine to Prevent Adverse Birth Outcomes in Papua, Indonesia

NCT05294406 is registered in ClinicalTrials.gov with Liverpool School of Tropical Medicine as lead sponsor.

NCT NCT05294406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05294406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Pilot Implementation of Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine to Prevent Adverse Birth Outcomes in Papua, Indonesia
Lead sponsor
Liverpool School of Tropical Medicine
Phase
Phase 4
Overall status
Completed
Start date
February 7, 2022
Completion date
December 31, 2023
Enrollment
2,128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria in pregnancy